Xiang Li
36Patents
5h-index
152Co-inventors
72Inventor score
Filing activity: Jan 7, 2003 → Feb 14, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8329742B2 | Macrocyclic compounds useful as pharmaceuticals | Emerging Cross-Sectional Technologies | 9 | Active |
| US7799827B2 | Macrocyclic compounds useful as pharmaceuticals | Emerging Cross-Sectional Technologies | 9 | Expired |
| US10323023B2 | Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof | Chemistry; Metallurgy | 6 | Active |
| US10329282B2 | Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof | Chemistry; Metallurgy | 5 | Active |
| US8093266B2 | Rho kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7314936B2 | Deazapurines and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US10954215B2 | Compounds as modulators of ROR gamma | Chemistry; Metallurgy | 3 | Active |
| US8937056B2 | Multikinase inhibitors for use in the treatment of cancer | Human Necessities | 2 | Active |
| US11390609B2 | Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof | Chemistry; Metallurgy | 1 | Active |
| US8697911B2 | Rho kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8691814B2 | Deazapurines and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8609640B2 | Multikinase inhibitors for use in the treatment of cancer | Human Necessities | 1 | Active |
| US9242989B2 | Compounds as modulators of RORγ | Chemistry; Metallurgy | 1 | Active |
| US11453690B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11414444B2 | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US12180243B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US7524883B2 | Eponemycin and epoxomicin analogs and uses thereof | Human Necessities | 0 | Expired |
| US11160783B2 | Multikinase inhibitors for use in the treatment of cancer | Human Necessities | 0 | Active |
| US11142689B2 | Yttrium-doped barium fluoride crystal and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9745267B2 | Compounds as modulators of RORC | Chemistry; Metallurgy | 0 | Active |
| US12312625B2 | Engineering strain producing cordycepin and its derivative 3′-deoxyinosine, its preparation method and application | Emerging Cross-Sectional Technologies | 0 | Active |
| US10836786B2 | Crystal form of dapagliflozin intermediate and preparation method therefor | Chemistry; Metallurgy | 0 | Active |
| US9745297B2 | Compounds as modulators of RORC | Chemistry; Metallurgy | 0 | Active |
| US11725006B2 | Hydrophilic berberine-type derivative and application thereof in preparing drug | Chemistry; Metallurgy | 0 | Active |
| US7868002B2 | Deazapurines and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.